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Abstract
Background: Acute respiratory tract infections are one of the major causes of morbidity and mortality among
young children in developing countries. Information on the viral aetiology of acute respiratory infections in
developing countries is very limited. The study was done to identify viruses associated with acute lower respiratory
tract infection among children less than 5 years.
Method: Nasopharyngeal samples and blood cultures were collected from children less than 5 years who have
been hospitalized for acute lower respiratory tract infection. Viruses and bacteria were identified using Reverse
Transcriptase Real-Time Polymerase Chain Reaction and conventional biochemical techniques.
Results: Out of 128 patients recruited, 33(25.88%%, 95%CI: 18.5% to 34.2%) were positive for one or more viruses.
Respiratory Syncytial Virus (RSV) was detected in 18(14.1%, 95%CI: 8.5% to 21.3%) patients followed by
Adenoviruses (AdV) in 13(10.2%, 95%CI: 5.5% to 16.7%), Parainfluenza (PIV type: 1, 2, 3) in 4(3.1%, 95%CI: 0.9% to
7.8%) and influenza B viruses in 1(0.8%, 95%CI: 0.0 to 4.3). Concomitant viral and bacterial co-infection occurred in
two patients. There were no detectable significant differences in the clinical signs, symptoms and severity for the
various pathogens isolated. A total of 61.1% (22/36) of positive viruses were detected during the rainy season and
Respiratory Syncytial Virus was the most predominant.
Conclusion: The study has demonstrated an important burden of respiratory viruses as major causes of childhood
acute respiratory infection in a tertiary health institution in Ghana. The data addresses a need for more studies on
viral associated respiratory tract infection.
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Background
Acute respiratory infections (ARI) are one of the major
causes of morbidity and mortality in young children
throughout the world especially in developing countries
[1,2]. Data from WHO estimated the burden of ARI at
94,037,000 disability-adjusted life years (DALYs) and 3.9
million deaths in 2001 [3]. Similar report from a meta-
analysis study demonstrates that throughout the world
1.9 million (95% CI 1.6-2.2 million) children died from
ARI in 2000, 70% of them in Africa and Southeast Asia
[2]. A further systematic analysis also estimated 1.575
million (uncertainty range: 1.046 million - 1.874 million)
deaths of children worldwide in 2008 as due to ARI [4].
Majority of acute lower respiratory tract infections
(ALRTI) in developed countries have been reported to be
often due to viral pathogens of which most common are
RSV, PIV, influenza viruses, Adv, human Coronaviruses
and Bocaviruses [5-7]. On the contrary, information on
these viruses in developing countries is limited probably
due to paucity of modern diagnostic molecular techniques.
These infections are therefore treated unsuccessfully with
antibiotics based on suspicion of bacterial causes [8].
A p a r tf r o mt h ep u b l i ch e a l th concern of nosocomial
infections that are associated with viral respiratory infec-
tions [9,10], significant costs derived from long duration
of hospitalization and several healthcare visits could also
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child mortality in developing countries including Ghana.
Lessons from the outbreak of the Severe Acute
Respiratory Syndrome (SARS) epidemics which resulted
in the death of 776 individuals [11] and the recent
emergence of a novel swine flu pandemic emphasize the
risk posed by respiratory viral infections in humans [12].
This study was done to determine the burden of
respiratory viruses among children hospitalized at the
Komfo Anokye Teaching Hospital for acute lower
respiratory illness using the Real Time Polymerase Chain
Reaction (RT-PCR).
Methodology
Study design
This was a hospital based cross-sectional study of chil-
dren less or equal to five years and hospitalized for
acute lower respiratory tract illness.
Study site
The study was performed at the children’sw a r do ft h e
Komfo Anokye Teaching Hospital (KATH), Ghana from
January to December 2008. KATH is approximately a
thousand bed tertiary medical facility located in Ashanti
Region, Kumasi, the confluence of the transportation net-
work in the central part of Ghana. Its position makes it
the most accessible tertiary and referral medical facility
in Ghana attending to a population of over 4.4 million in
the Ashanti region and beyond [13].
Sampling
To have a year round incidence of the various viral
agents, recruitment was done throughout the year 2008.
Screening and recruitment were started at the beginning
of every week till two or three patients were recruited.
After a maximum of three patients have been obtained it
was suspended till the beginning of the next week. This
cycle was repeated till the maximum of 11 patients were
recruited for each month.
At the recruitment station all patients arriving at the
unit were screened but only those less than five com-
pleted years were recruited. Patients recruited into the
study should have features of severe pneumonia or very
severe pneumonia as defined by the WHO-IMCI (World
Health Organisation Integrated Management of Child-
hood Illness) protocol [14,15]. Severe pneumonia was
said to be present if the child has a history of cough and/
or difficult breathing of less than 3 weeks duration, with
lower chest wall recession. Severe pneumonia in addition
to cyanosis and/or inability to feed or drink was classified
as very severe pneumonia. A child was recruited into the
s t u d yo n l ya f t e rt h eg u a r d i a no rp a r e n t sh a dc o n s e n t e d
after the objectives of the study had been explained in
English or the local dialect. A standardized case record
form was then used to record the history of the illness as
well as the presenting clinical features of pneumonia.
Five (5 ml) of blood sample was then taken into 25 ml
of Brain Heart Infusion Broth (BHIB) and quickly sent to
the bacteriological laboratory for culture. Nasopharyngeal
specimens were also taken using the nasopharyngeal
flocked swab (Copan, Italy). The swab was gently inserted
up the nostril towards the pharynx until resistance was
felt and then rotated 3 times to obtain epithelial cells. It
was then withdrawn and put into 2.5 ml phosphate buf-
fered saline (X1). The samples were transported on ice to
the laboratory within few hours of collection. They were
then vortexed, transferred into 1.5 ml eppendorf tubes
(Eppendorf, Germany) and kept at -80°C for Polymerase
Chain Reaction (PCR). Both samples were taken by
experienced prior trained nurses of the children ward.
Children were excluded if both samples could not be
obtained for any reason.
Viral identification
Viral nucleic acids were extracted from samples using
QIAamp viral mini kit (Qiagen, Germany) according to
the manufacturers’ instruction [16]. RT-PCR amplifica-
tion was performed for the detection of Adv, RSV, Influ-
enza A (Flu A), Influenza B (Flu B), Parainfluenza 1(PIV
1), Parainfluenza 2 (PIV 2) and Parainfluenza 3 (PIV 3)
using the light cycler version 1.5 (Roche, Germany). Pri-
mers highly specific to each of the viruses were used
(Table 1). The reaction mixture for RNA viruses was
made up of 5 μlo fR N Ae x t r a c t ,1μl deoxynucleotide
(dNTP) triphosphate (10 mM) (Qiagen), 1 μlB o v i n e
Serum Albumin (BSA)(1 mg/ml)(Qiagen), 12.5 μl Qiagen
One Step RT-PCR Buffer x5 (containing 12.5 mM
MgCl2)( Q i a g e n ) ,1μl Qiagen One Step Enzyme Mix, 1
μl each of sense and antisense primer(10 μM each), 0.5 μl
Probe and 2.0 μl of RNase free water. DNA virus reaction
mixture was made up of 5 μl PCR buffer (10X), 1 μlo f
dNTP mix (10 mM each), 1 μlo fM g C l 2 (50 mM), 0.5 μl
of Hot Star Taq DNA Polymerase, 0.5 μl of probe, 1 μlo f
BSA (1 mg/ml) and 1 μl each of sense and antisense
primers.
The PCR conditions for PIV, RSV and Influenza viruses
consisted of an initial reverse transcription at 20 minutes
for 50°C, Taq DNA polymerase activation at 95°C followed
by forty five (45) cycles of denaturation at 15 seconds for
95°C and annealing at 15 seconds for 58°C. The initial
reverse transcription step was omitted in the case of Adv.
Controls and standards
For each batch of tests that were run, RNase free water
(Qiagen, Germany) was used as negative control and in
vitro transcribed gene of the various viruses was used to
determine the detection limit of the assay as positive con-
trol. The in vitro transcripts were prepared in our
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Bonn, Germany) and transported to Ghana via cooling
chain. The in vitro transcripts were prepared by amplify-
ing the genes of interest of the viruses with specific set of
primers. The products were ligated to the PCR2.1 vector
using the TOPO TA cloning kit (Invitogen Corp, Carls-
bad, CA) and transformed into competent E.coli cells.
After overnight incubation, desirable colonies were
selected and purified using Qiamp Spin-Miniprep Kit
(Qiagen, Germany). PCR was performed on the purified
product and RNA transcripts were then synthesized from
the lowest dilution (with clear band) using Ambion
Megascripts T3 kit (Invitogen corp, Calsbad, CA). The
final products were purified using Rneasy Mini Kit (Qia-
gen, Germany) and the concentrations of the transcripts
were determined using a spectrophotometer (Themos-
cientific, U.S.A). The copy numbers of the RNA tran-
scripts were determined following the method of
Fronhoffs [21]. Ten-fold dilutions of the RNA transcripts
were prepared in Carrier RNA-RNase free water (310 μg
of Carrier RNA in 310 ml of RNase free water) and
tested. The detection limit was determined as the last
dilution after which all other replicates gave negative
results. The detection limits were Respiratory Syncytial
Virus (RSV): 20 copies/μl, PIV 1: 1 - 78 copies/μl, PIV 2:
400 copies/μl, PIV 3: 30 copies/μl, Influenza A: 120
copies/μl and Influenza B: 480 copies/μl.
To determine the specificities, our assays were tested
on other different viruses and they turn out negative.
Bacteria identification
Bacterial isolates were identified using conventional bio-
chemical methods including urease and indole production,
citrate utilization, hydrogen sulphide, gas production and
fermentation of sugars. The biochemical media used
included Simon’s Citrate medium, Urea and Triple Sugar
Iron agar (TSI). Coagulase tests were performed for all sta-
phylococci organisms.
Statistical analysis
Data obtained was double entered into a spreadsheet
database prepared with Microsoft
® Excel. It was then
compared and cleaned for abnormal wrongful entries.
Statistical analysis was done using STATA SE statistical
software version 11.2(Texas, USA) after the data had
been imported. Categorical variables such as age groups
and their association with respiratory agents were ana-
lyzed using the Fischer’s exact test. Continuous variables
Table 1 Target genes and primer sequences for respiratory pathogens
Virus Target gene Function Oligonucleotide sequence
RSV
a (A/B) Matrix gene [17] Forward primer 5’-GGAAACATACGTGAACAAGCTTCA
Reverse primer A 5’-CATCGTCTTTTTCTAAGACATTGTATTGA
Reverse primer B 5’-TCATCATCTTTTTCTAGAACATTGTACTGA
Probe 6FAM-TGTGTATGTGGAGCCTT- MGBNFQ
Adenovirus Hexon gene [18] Forward primer 5’-GCCACGGTGGGGTTTCTAAACTT
Reverse primer 5’-GCCCCAGTGGTCTTACATGCACAT
Probe 6FAM-TGCACCAGACCCGGGCTCAGGTACTCCGA-TAMRA
PIV I
b Polymerase gene [19] Forward primer 5’-ACAGATGAAATTTTCAAGTGCTACTTTAGT
Reverse primer 5’-GCCTCTTTTAATGCCATATTATCATTAGA
Probe 6FAM-ATGGTAATAAATCGACTCGCT- MGBNFQ
PIV II
c Polymerase gene [19] Forward primer 5’-TGCATGTTTTATAACTACTGATCTTGCTAA
Reverse primer 5’-GTTCGAGCAAAATGGATTATGGT
Probe 6FAM-ACTGTCTTCAATGGAGATAT- MGBNFQ
PIV III
d Matrix gene [19] Forward primer 5’-TGCTGTTCGATGCCAACAA
Reverse primer 5’-ATTTTATGCTCCTATCTAGTGGAAGACA
Probe 6FAM-TTGCTCTTGCTCCTCA- MGBNFQ
Influenza A Matrix gene [20] Forward primer A1 5’-GGACTGCAGCGTAGACGCTT
Forward primer A2 5’-CATCCTGTTGTATATGAGGCCCAT
Reverse primer 5’-CATTCTGTTGTATATGAGGCCCAT
Probe 6FAM-CTCAGTTATTCTGCTGGTGCACTTGCCA- MGBNFQ
Influenza B Hemagglutinin (HA)gene [20] Forward primer 5’-AAATACGGTGGATTAAATAAAAGCAA
Reverse primer 5’-CCAGCAATAGCTCCGAAGAAA
Probe 6FAM-CACCCATATTGGGCAATTTCCTATGGC- MGBNFQ
RSV
a, Respiratory syncytial virus; PIV I
b, Parainfluenza virus type 1; PIV II
c, Parainfluenza virus type 2, PIV III
d, Parainfluenza virus type 3.
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ranges. A non-parametric K-sample test on the equality
of medians was used to evaluate the differences in the
medians of the various subgroups of the continuous vari-
ables. For all analysis done, a p-value of less than 0.05
was considered statistically significant.
Ethical approval
The study protocol was approved by the Committee for
Human Research, Publications and Ethics (CHRPE) of
KATH and School of Medical Sciences, KNUST,
Kumasi, Ashanti region, Ghana.
Results
A total of 128 patients were recruited over the period of
January to December 2008. The median age of the
patients was 12 months (IQR: 6-24 months) and the
number of males was 81(63.3%). Sixty one (47.7%) had
severe pneumonia with the rest diagnosed as very severe
pneumonia. At least one respiratory virus was detected in
33 (25.7%, 95%CI: 18.5% to 34.2%) children. Multiple
viral infections were detected in 2 patients. One had an
RSV and PIV 1 co-infection whiles the other had a com-
bination of RSV, Influenza B and Adenovirus co-infec-
tion. Bacteria was isolated from only 12 (9.4%, 95%CI: 4.9
to 15.8%) patients with 10 of these being Staphylococcus
aureus. The other two were Klebsiella species and Coli-
form.R S Va n dStaphylococcus aureus coinfection was
also identified in two patients.
Six (20.0%) out of 30 children less than six months of
age were found to be positive for viral infection (Table 2).
The highest number of children infected were between 6
months and 2 years, the proportions infected for the var-
ious age groups were however not significantly different.
Clinical presentation of patients were compared to
general pathogens identified (Table 3) and the individual
viral pathogens (Table 4). Generally, there were no
detectable significant differences in the clinical presenta-
tion as well as the gender and duration of illness of
patients for the various pathogens isolated.
The study also investigated the seasonal variation of
viruses. RSV infections were detected throughout the
year however the peak infection rate occurred during
the minor rainy seasons (October) (Figure 1). Adeno-
virus infections on the other hand had two main peaks
occurring in the month of April and October.
Discussion
Viral agents play an important role in acute lower
respiratory infections and may herald the onset of pneu-
monia caused by secondary bacterial infections [22].
Although information on the causes of respiratory ill-
ness in tropical countries is very scanty, available data
indicates about one -third of the cases of respiratory
tract infections are due to viruses [23].
The present study identified viruses in 25.8% of patients
hospitalized for ALRTI with RSV being the most predomi-
nant. The overall prevalence is comparable to previous stu-
dies done in other developing countries [24] and the
predominance of RSV is in accordance with the assertion
that this virus is the single most frequent lower respiratory
tract pathogen in infants and young children worldwide
[25-27].
Adenoviruses, the second highest viruses detected in
this study have been reported to be responsible for 5-
10% of lower respiratory tract infections with the high-
est rate occurring in younger children [28-31]. Our
study similarly recorded a 10.2% detection rate of Ade-
noviruses however there was no statistical difference in
the age specific prevalence. This could possibly be due
to the few number of younger children (less than one
year) enrolled in this study.
This study generally recorded higher cases of tachyp-
noea, chest recessions and very severe pneumonia in
RSV compared to Adenovirus infected patients but the
differences were not statistically significant. Although
similar clinical presentations have been found to be
associated with RSV [32,33], our small sample size
could account for our inability to detect these
differences.
Table 2 Association between age groups and respiratory virus infection
Age (months)
≤ 5 6 to 23 24 to 60 p-value
(n = 30) (n = 59) (n = 39)
Infections
Patients infected with at least one virus, no.(%) 6(20.0) 18(30.5) 9(23.1) 0.549
Respiratory syncytial virus, no (%) 4(13.3) 9(15.3) 5(12.8) 1.000
Adenovirus, no. (%) 2(6.7) 8(13.6) 3(7.7) 0.596
Parainfluenza 1, no. (%) 0 (0.0) 1(1.7) 1 (2.6) 1.000
Parainfluenza 3, no. (%) 0 (0.0) 2(3.4) 1(2.6) 0.798
Influenza B, no.(%) 0 (0.0) 1(1.7) 0 (0.0) 1.000
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viral or bacterial infections were found to be higher (p =
0.03). Poor feeding and malnutrition has generally been
associated with less risk for respiratory viral infection in
developing countries [34-36] however the possibility of
increased mortality could occur especially when bacter-
ial infections are involved. Further case controlled stu-
dies are therefore needed in developing countries to
investigate this observation
There have been fewer studies of PIV infections in devel-
oping countries and most of them do not differentiate the
subtypes of the viruses. Our study recorded a 3.1% preva-
lence of PIV infections with the predominant type being
PIV-3. Similar hospital based studies have been reported in
other developing countries [37-40]. PIV infections have
been strongly associated with croup [41,42]. The present
study recorded no case of croup among PIV patients.
Viral associated bacteremia was detected in two
patients (1.7%). Low rate of secondary bacterial infec-
tions has generally been reported in developing coun-
tries with the isolation rate varying between 2 and 10%
[43-45]. Studies in some developed countries however
Table 3 Distribution of clinical presentation and microbial isolation
Microbial Isolation
Presentation None
(n = 85)
Virus
(n = 31)
Bacteria
(n = 10)
Bacteria & Viruses
(n = 2)
Total
(n = 128)
*p-value
Age(months) median(IQR) 12(5-25) 11(6-19) 17(8-24) 48(36-60) 128(100%) 0.282
Temperature median(IQR) 38(37.8-38.5) 38(37.7-38.6) 37.8(37.4-38.0) 37.8(37.4-38) 128(100%) 0.134
Duration of illness (days) median(IQR) 4 (3-6) 4(3-5) 6.5(4-14) 4.5(4-5) 4 (3-6) 0.187
Sex (male) n(%) 54(63.3) 20(64.5) 5(50.0) 2(100.0) 81(63.3) 0.668
Tachypnoea n (%) 61(71.8) 18(58.1) 6(60.0) 1(50.0) 86(67.2) 0.382
Chest recessions n (%) 80(94.1) 29(93.6) 9(90.0) 2(100.0) 120(93.4) 0.751
Wheeze n (%) 31(36.5) 14(45.2) 3(30.0) 2(100.0) 50(39.1) 0.268
Cyanosis n (%) 3(3.4) 3(5.5) 0 (0.0) 1(50.0) 7(5.3) 0.07
Poor feeding n (%) 48(56.5) 10(32.3) 3(30.0) 0 61(47.7) 0.029
Diarrhea n (%) 14(16.5) 4(12.9) 3(30.0) 0 21(16.4) 0.606
Vomiting n (%) 25(29.4) 8(25.8) 1(10.0) 1(50.0) 35(27.3) 0.461
Severe Pneumonia n (%) 35(41.2) 18(58.1) 7(70.0) 1(50.0) 61(47.7) 0.142
Very severe Pneumonia n (%) 50(58.8) 13(41.9) 3(30.0) 1(50.0) 67(52.3) 0.142
* p-values determined assuming the null hypothesis that the proportions of the clinical presentations are uniform among the various subgroups (i.e. none, viral,
bacterial or bacterial and viral infections) for categorical variables or their medians for continuous clinical variables
Table 4 Clinical presentations of patients infected with individual respiratory viruses
Respiratory Viruses
Clinical Presentation RSV
(n = 18)
Adv
(n = 13)
PIV-1
(n = 1)
PIV-3
(n = 3)
Flu B
(n = 1)
Temperature median(IQR) 38(37.7-38.2) 37.9(37.4-38.5) 37.5(37.5-37.5) 38.6(38.2-39) 38.8(38.8-38.8)
Duration of illness
median(IQR)
4(3-5) 3 ((2-6) 4(4-4) 3((2-4) 6(6-6)
Sex (male) n(%) 13(72.2) 9(69.2) 1(100.0) 1(33.3) 1(100)
Tachypnoea n(%) 11(61.1) 7(53.9) 0 2(66.7) 1(100)
Chest recessions n(%) 17(94.4) 12(92.3) 1(100.0) 3(100) 1(100)
Wheeze n(%) 9(50.0) 8(61.5) 0 3(100) 1(100)
Cyanosis n(%) 1(5.6) 3 (23.1)
a 0 3(100) 1(100)
Poor feeding n(%) 8(44.4) 1(7.7)
b 0 1(33.3) 0
Diarrhea n(%) 1(5.6) 1(7.7) 0 3(100) 0
Vomiting n(%) 6 (33.3) 1(7.7) 0 3(100) 0
Severe Pneumonia n(%) 9(50.0) 9(69.2) 1(100.0) 3(100) 1(100)
Very severe Pneumonia n (%) 9(50.0) 4(30.8) 0 3(100) 0
RSV; Respiratory syncytial virus; PIV-I, Parainfluenza virus type 1, PIV-III; Parainfluenza virus type 3,Adv; Adenovirus, Flu B; Influenza B. Parainfluenza type 2 and
Influenza A were not detected in clinical samples.
aP = 0.03 vs patients having cyanosis and infected with adenovirus.
bP = 0.02 vs patients who were poorly fed
with adenovirus infection.
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sensitivity of the bacteria identification techniques used.
The blood culture identification system used in this
study may be limited in the detection of bacteria asso-
ciated with lower respiratory tract infection. Perhaps the
detection rate could have increased if the present study
had identified bacterial pathogens from nasopharyngeal
aspirates or washings as reported by Hishinki et al. [47].
The isolation of Staphylococcus aureus in an RSV posi-
tive patient in the present study was similar to studies
reported by Berman et al., [48] and Cherian et al., [43]. In
their case, the bacterium was associated with fatality in
the children.
The present study observed that all subjects enrolled in
this study were treated empirically with antibiotics in
accordance with the paediatric emergency treatment pro-
tocol for managing severe and very severe pneumonia.
Similar occurrences have been reported where patients
were treated unsuccessfully with multiple antibiotics [8].
Policy makers may therefore consider reviewing the clini-
cal algorithm for patient management as the economic
cost both to the health service and the patient’sh o u s e -
hold derived from the use of antibiotics could be
enormous.
The period of this study experienced major rainfalls in
the months of May to July and minor rainfalls in the
month of September to October. The month of October
recorded the highest detection of viral infections (57.6%;
19/33) with the commonest being RSV. This phenom-
enon has been reported in other developing countries
[43,49]. The occurrence of RSV infections in the rainy
and cold season could be due to overcrowding as a result
of populations staying more to their homes. More studies
are however needed to define the seasonality of respira-
tory viruses in tropical countries.
Our study had some limitations which include under-
estimation of the overall prevalence of respiratory
viruses since we did not test for coronaviruses, human
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Figure 1 Monthly distribution of viruses. The figure describes the various viruses identified from January to December 2008. RSV: Respiratory
Syncytial Viruses; Inf A: Influenza A virus; Inf B: Influenza B virus; PARA 1: Parainfluenza type 1 virus; PARA II: Parainfluenza type 2 virus; PARA III:
Parainfluenza type 3 virus.
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have also been reported in hospitalized patients. Also
the negative results recorded for Influenza A and PIV 2
and the low prevalence of influenza B in our samples
could be due to the low sensitivity of the assay for these
viruses. The limit of detections of Influenza A, Influenza
B and PIV 2 are 120 copies/μl, 480 copies/μl and 400
copies/μl respectively as such viral copies below these
limits of detections could be missed by our assay.
Conclusion
This study has demonstrated that respiratory viruses are
associated with a considerable number of hospital
admissions in Ghana. Hospitalized children presenting
with symptoms of ALRTI may not necessarily need
treatment with antibiotics but rather antiviral drug
options could be explored. The importance of further
cross-sectional and longitudinal studies of viral-asso-
ciated respiratory infections among out-patients and
healthy populations cannot be over emphasized. This
will contribute immensely to overcoming the paucity of
data on the importance of respiratory associated viruses
to the burden of disease and the morbidity and mortal-
ity of under five children.
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